Reproductive and hormonal factors in relation to survival and platinum resistance among ovarian cancer cases.

Abstract

BACKGROUND:

Ovarian cancer survival is poor, particularly for platinum-resistant cases. The previous literature on pre-diagnostic reproductive factors and ovarian cancer survival has been mixed. Therefore, we evaluated pre-diagnostic reproductive and hormonal factors with overall survival and, additionally, platinum-chemotherapy resistance.

METHODS:

We followed 1649 invasive epithelial ovarian cancer cases who were enrolled between 1992 and 2008 for overall mortality within the New England Case-Control Study and abstracted chemotherapy data on a subset (n=449). We assessed pre-diagnostic reproductive and hormonal factors during in-person interviews. We calculated hazard ratios (HRs) using Cox-proportional hazards models.

RESULTS:

We observed 911 all-cause deaths among 1649 ovarian cancer cases. Self-reported endometriosis and longer duration of hormone therapy use were associated with improved survival (HR: 0.72; 95% confidence interval (CI): 0.54-0.94 and HR, ⩾5 years vs never: 0.70; 95% CI: 0.55-0.90, respectively). Older age at menopause and menarche were associated with worse survival (HR, ⩽50 vs >50 years: 1.23; 95% CI: 1.03-1.46 and HR, 13 vs <13 years: 1.24; 95% CI: 1.06-1.44, respectively). We observed no association between oral contraceptive use, parity and tubal ligation, and overall survival. No significant associations were observed for any of the reproductive and hormonal factors and platinum resistance.

CONCLUSIONS:

These results suggest that pre-diagnostic exposures such as endometriosis and HT use may influence overall survival among ovarian cancer patients.

• Authors: Amy L Shafrir, Ana Babic, Rulla M Tamimi, Bernard A Rosner, Shelley S Tworoger, Kathryn L Terry
• Journal: British journal of cancer (Br J Cancer) Vol. 115 Issue 11 Pg. 1391-1399 (Nov 22 2016) ISSN: 1532-1827 [Electronic] England
• PMID: 27701384 (Publication Type: Journal Article)

Chemical References

• Antineoplastic Agents
• Platinum

Topics

• Adult
• Antineoplastic Agents (therapeutic use)
• Drug Resistance, Neoplasm
• Female
• Humans
• Menarche
• Menopause
• Middle Aged
• Ovarian Neoplasms (drug therapy, pathology, physiopathology)
• Platinum (therapeutic use)
• Survival Analysis
• Survival Rate